What Are the Chances of Getting Lung Cancer From Vaping?

Nobody can give you a reliable percentage, and anyone who does is guessing. Lung cancer typically takes around twenty years of exposure to develop, and e-cigarettes have only been widely used since the early 2010s. What researchers can say is that vape aerosol contains known carcinogens at levels far below those in cigarette smoke, that cancer-potency modeling puts most e-cigarettes at less than one percent of the cancer risk of tobacco, and that mice exposed to e-cigarette vapor for about a year developed lung tumors at meaningful rates. Piecing together what those findings mean for a human vaper over a lifetime is the central challenge, and the honest answer is that the science is still catching up.

Why a Definitive Risk Number Does Not Exist Yet

Lung cancer has one of the longest latency periods of any malignancy. A person who starts smoking at eighteen may not develop a detectable tumor until their forties or fifties. Because mass-market vaping only took off around 2012, the longest anyone could have vaped exclusively is roughly thirteen years, and most regular vapers have far less exposure than that. Two recent systematic reviews looking for direct evidence of lung cancer in vapers came up largely empty-handed. One noted that the small number of eligible studies, their observational design, and short follow-up periods “restrict causal inference” and limit assessment of the latency factor that matters most in cancer.¹ The other pointed out that the longest prospective dataset available covered only two years of follow-up, which “is not enough for developing cancer,” and emphasized that lung cancer’s roughly twenty-year latency means we need to track vapers for much longer before population-level cancer data become meaningful.²

So the question becomes: in the absence of decades of human data, what can laboratory chemistry, biomarker studies, animal experiments, and cancer-potency models tell us about the likely direction and magnitude of the risk?

What Is Actually in Vape Aerosol

E-cigarette vapor is not water vapor. When the liquid (a mix of propylene glycol, vegetable glycerin, nicotine, and flavorings) is heated by a metal coil, it produces an aerosol carrying a range of chemicals. The ones most relevant to cancer risk fall into two categories: volatile carbonyls and metals.

Formaldehyde and acetaldehyde are the carbonyls that get the most attention, because both are classified as carcinogens or probable carcinogens by international health agencies. One study measuring median formaldehyde concentrations in e-cigarette vapor found levels around 626 micrograms per cubic meter, which exceeded the workplace safety ceiling set for occupational exposure.³ That sounds alarming, but context matters: a vaper takes a few hundred puffs per day, not continuous eight-hour occupational-level inhalation. Even so, the presence of formaldehyde at those concentrations means the aerosol is not biologically inert.

Metals are the other concern. The heating coil itself is a source of contamination. Studies have found cadmium, chromium, lead, manganese, and nickel in both the e-liquid and the aerosol, with marked variability between brands and even between units of the same brand.⁴ Much of this contamination appears to come from the coil transferring metal into the liquid, and from the liquid carrying it into the inhaled aerosol.⁵ One lab analysis found that after e-liquid sat in contact with certain coil types, nickel levels jumped by a factor of roughly 180,000 compared to the liquid in its original bottle.⁶ Nickel and chromium are known or suspected lung carcinogens, so this is not a trivial finding.

What Animal Studies Show

The strongest evidence that vaping can cause cancer in a living organism comes from a widely cited mouse study. Researchers exposed mice to e-cigarette smoke for 54 weeks and found that about 22.5 percent of them developed lung adenocarcinoma, a type of lung cancer. More than half also developed bladder urothelial hyperplasia, a precancerous condition. These outcomes were extremely rare in control mice breathing filtered air or a nicotine-free vehicle.⁷

Earlier work by the same research group had shown how this might happen at the molecular level. E-cigarette smoke caused DNA damage in mouse lung, heart, and bladder tissue, while also reducing the cells’ ability to repair that damage. Specifically, the activity of key DNA-repair proteins was significantly diminished in the lung.⁸ A separate study found that e-cigarette aerosol triggered measurable oxidative stress and inflammatory responses in mouse lung tissue, conditions that are broadly associated with cancer development over time.⁹

These findings are important but come with caveats. Mice are not humans, and the exposure conditions in laboratory studies often do not mirror how people actually vape. The mice were continuously exposed in enclosed chambers, which may overstate the dose a typical human vaper inhales. Still, the fact that lung tumors appeared at all in a controlled experiment moves the concern beyond speculation.

How Vaping Compares to Smoking in Cancer Potency

If you are trying to calibrate your worry, the comparison that matters most is vaping versus smoking. Several research groups have tried to quantify this gap. One cancer-potency model used published chemical analyses of e-cigarette emissions and applied standard inhalation risk formulas to estimate lifetime cancer risk. The result: the great majority of e-cigarette products had a calculated cancer potency of less than one percent of tobacco smoke’s potency and fell within about two orders of magnitude of a medicinal nicotine inhaler. Lifetime cancer risks declined sharply in the sequence of combustible cigarettes, then heat-not-burn devices, then normal-power e-cigarettes.¹⁰ A separate analysis using a similar method confirmed that both e-cigarettes and heated tobacco products showed cancer risk reduced by more than one order of magnitude compared to cigarettes.¹¹

Human biomarker data broadly support those models. A comparison of volatile organic compound metabolites in the urine of people who vaped versus people who smoked found that concentrations of nearly all carcinogen metabolites were significantly higher during cigarette use than during e-cigarette use. The differences ranged from roughly 1.3 times higher for a butadiene metabolite to about seven times higher for an acrylonitrile metabolite.¹² A large national survey also found that smokers had far higher levels of NNAL, a tobacco-specific lung-carcinogen marker, compared to non-vaping non-smokers, while vapers who did not smoke showed no significant increase in NNAL.¹³

This is probably the most useful framing for most people: the chemical fingerprint of vaping looks much closer to not smoking than to smoking, but it is not the same as breathing clean air. There is a real gap between zero risk and one percent of cigarette-level risk, and whether that gap matters to you depends on how many years you vape and what alternative you are comparing to.

Why Device Settings and Coil Temperature Change Everything

One thing that makes vaping risk difficult to pin down is that not all vaping is the same. The device you use, how much power it draws, and the condition of your coil can dramatically change what you inhale. When researchers increased the voltage on a single-coil device from 3.3 to 4.8 volts, the total aldehyde emissions roughly tripled, and acrolein, a particularly toxic aldehyde, jumped by a factor of ten. Reusing the coil many times without replacing it made things worse, with aldehyde emissions rising more than 60 percent due to the buildup of polymer residue on the coil.¹⁴

Temperature is the key variable. A study that measured coil surface temperature using infrared imaging found a steep increase in toxic carbonyls once the coil reached about 200 to 250 degrees Celsius, which corresponded to a battery output of around 15 watts.¹⁵ Lower-resistance coils running at the same voltage also produced higher aerosol temperatures and more liquid consumption per puff.¹⁶

The practical takeaway is that running a device at high wattage, using sub-ohm coils, and neglecting coil replacement all push the chemical profile of the aerosol toward higher carcinogen levels. A person chain-vaping on a high-powered mod with a gunked-up coil is inhaling a very different chemical cocktail than someone taking occasional puffs on a low-wattage pod system. That first cancer-potency model noted that while most e-cigarette products had potencies well under one percent of cigarette smoke, “a small minority have much higher potencies.”¹⁰ Device choice and usage habits likely explain much of that spread.

Flavorings as a Wildcard

The flavor in your vape liquid is not just a marketing gimmick; it is a chemical that gets heated and potentially breaks down into something you did not bargain for. Research has found that thermal decomposition of flavoring compounds can actually dominate aldehyde formation during vaping, producing aldehyde levels that exceed occupational safety limits. The effect scales exponentially with flavoring concentration: more flavor means disproportionately more aldehydes.¹⁷ Work on the chemistry of how this happens has shown that terpenes, a class of compounds commonly used for citrus and fruit flavors, can produce formaldehyde when they interact with free radicals and oxygen on a hot coil.¹⁸

Ethyl ester flavor additives, common in sweet and fruity profiles, present a different concern. While they are considered safe to eat, heating them decomposes them into carboxylic acids, which can then further break down into ketene, a compound described as a strong respiratory poison capable of causing fatal lung damage at very low concentrations.¹⁹ The phrase “generally recognized as safe” was created for food, not for inhalation at high temperatures, and this distinction is one of the least appreciated aspects of vaping chemistry.

The Dual-Use Trap

Many people who vape also continue to smoke cigarettes, and this dual-use pattern may be the most practically important risk scenario to understand. A case-control study of early-onset lung cancer found that people who both vaped and smoked had an odds ratio of about 13.8 for lung cancer compared to non-users, almost 2.8 times higher than the odds ratio of roughly 5.0 for people who smoked alone.²⁰ That is a striking signal, though the study is observational and the sample of dual users was small, so researchers caution against drawing firm causal conclusions from it.

A population-based cross-sectional study looked at the biomarker side of this question and found that dual users had nicotine and toxicant exposure at least at the same level as exclusive cigarette smokers, and higher than exclusive vapers across most measures. The exception was metals, where vapers’ exposure was elevated regardless of whether they also smoked.²¹ If you are vaping as a way to cut down on cigarettes but still lighting up a few a day, the evidence suggests you are not meaningfully reducing your carcinogen exposure. The harm-reduction benefit of vaping seems to depend on fully replacing combustible tobacco, not supplementing it.

Secondhand Vape Exposure and Cancer Risk

Bystanders around vapers are exposed to some of the same chemicals, but at much lower levels than those near cigarette smokers. Indoor air measurements have shown that the average nicotine concentration from e-cigarettes was about one-tenth of the level produced by cigarettes.²² When researchers estimated excess lifetime cancer risk for passive exposure, the risk for people near vapers was roughly five orders of magnitude smaller than for people near smokers. Cumulative respiratory doses for passive smokers were up to fifteen times higher than for passive vapers.²³ Five orders of magnitude is a factor of 100,000, which puts secondhand vape exposure in a very different category from secondhand smoke. That does not mean zero risk, but it is vanishingly small by comparison.

Cannabis Vaping as a Separate Concern

When most people ask about “vaping and lung cancer,” they are thinking of nicotine, but cannabis vaping has grown enormously and brings its own chemistry. A study comparing the pulmonary effects of vaping cannabidiol (CBD) versus nicotine found that CBD aerosol caused greater inflammatory changes, more severe lung damage, and higher oxidative stress than nicotine aerosol. CBD aerosol was also more toxic to human lung cells in culture.²⁴ This does not directly prove that cannabis vaping causes cancer, but the inflammatory and oxidative-stress pathways it activates are the same ones that contribute to cancer development over time. If you vape THC or CBD products, the risk profile is likely different from, and possibly worse than, nicotine vaping in terms of lung tissue damage, though dedicated cancer studies for cannabis vaping are even further behind than those for nicotine vaping.

Cannabis vape cartridges also introduced the EVALI crisis in 2019, which was largely traced to vitamin E acetate used as a cutting agent in illicit THC products. EVALI was an acute lung injury, not cancer, but it underscored the point that the contents of a vape cartridge vary wildly depending on the source, and unregulated products can contain substances that regulated ones do not. For anyone concerned about long-term lung health, the provenance of your vape product is not a minor detail.